The pharma giant has almost doubled the size of its workforce over the last five years but is now looking to tighten cost ...

The pharma giant cut its guidance and named a new CEO, hoping to revive growth. Its stock fell as much as 30%, wiping almost $93 billion from its market value.

BP has been under ongoing pressure from investors for underperforming compared to its rivals in recent years. In February, BP ...

BP will review its portfolio of assets and consider further cost cuts as part of a drive to do better for shareholders, the oil major said on Tuesday, as it reported a second-quarter profit that ...

BP will launch a review of how best to develop and monetise its oil and gas production assets and consider more cost cuts to boost shareholder returns, the oil major said on Tuesday, as it beat second ...